Sotatercept improves right ventricular function but is associated with new or worsening pericardial effusions: a CMR study in intermediate-high risk PAH - PubMed
3 hours ago
- #Pulmonary Arterial Hypertension
- #Pericardial Effusion
- #Cardiovascular Magnetic Resonance
- Sotatercept improves right ventricular (RV) function in patients with pulmonary arterial hypertension (PAH).
- Significant improvements observed in RV size, mass, function, and right atrial size.
- End-systolic interventricular septal curvature improved, indicating better RV afterload.
- 28% of patients developed new or worsening pericardial effusions without hemodynamic compromise.
- CMR is effective for tracking cardiac improvements and monitoring pericardial effusions in PAH patients on sotatercept.